A randomised controlled trial of roller versus centrifugal cardiopulmonary bypass pumps in patients undergoing pulmonary endarterectomy. 2015

F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, The Czech Republic.

OBJECTIVE There is some controversy as to whether there is a benefit from the use of a centrifugal pump compared with a roller pump during cardiopulmonary bypass to facilitate cardiac surgery. We compared the two pumps, with the primary aim of determining any difference in the effects on inflammation after pulmonary endarterectomy surgery which required prolonged cardiopulmonary bypass and deep hypothermic circulatory arrest. METHODS Between September 2010 and July 2013, 58 elective patients undergoing pulmonary endarterectomy were included in this prospective, randomised, controlled study; 30 patients were randomly allocated to the control group, which used a roller pump, and 28 patients to the treatment group, which used a centrifugal pump. Interleukin-6, procalcitonin, C-reactive protein, thromboelastographic parameters, P-selectin, international normalised ratio, activated prothrombin time, free haemoglobin, haematocrit, red blood cell count, white blood cell count, platelet count and protein S100β were recorded during and after the procedure. We also recorded the length of intensive care unit stay, blood loss and transfusion, neurological outcomes and respiratory and renal failure. RESULTS There was a significant difference in the primary outcome measure: Interleukin-6 was significantly higher in the roller pump group (587 ± 38 ng · l(-1) vs. 327 ± 37 ng · l(-1); p<0.001) 24 hours after surgery, which we interpreted as an increased inflammatory response. This was confirmed by a significant rise in the procalcitonin level in the roller pump group 48 hours following surgery (0.79 (0.08-25.25) ng · ml(-1) vs. 0.36 (0.02-5.83) ng · ml(-1); p<0.05). There were, however, no significant differences in clinical outcome data. CONCLUSIONS We have shown that the use of a centrifugal pump during prolonged cardiopulmonary bypass and deep hypothermic circulatory arrest is associated with a reduced inflammatory response compared to the standard roller pump. Larger multi-centre trials in this area of practice are required.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D005260 Female Females
D006353 Heart-Assist Devices Small pumps, often implantable, designed for temporarily assisting the heart, usually the LEFT VENTRICLE, to pump blood. They consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors. Artificial Ventricle,Heart Assist Device,Heart Ventricle, Artificial,Pumps, Heart-Assist,Vascular-Assist Device,Vascular-Assist Devices,Ventricle-Assist Device,Ventricular Assist Device,Artificial Heart Ventricle,Artificial Heart Ventricles,Artificial Ventricles,Assist Device, Heart,Assist Device, Ventricular,Assist Devices, Heart,Assist Devices, Ventricular,Device, Heart Assist,Device, Heart-Assist,Device, Vascular-Assist,Device, Ventricle-Assist,Device, Ventricular Assist,Devices, Heart Assist,Devices, Heart-Assist,Devices, Vascular-Assist,Devices, Ventricle-Assist,Devices, Ventricular Assist,Heart Assist Devices,Heart Ventricles, Artificial,Heart-Assist Device,Heart-Assist Pump,Heart-Assist Pumps,Pump, Heart-Assist,Pumps, Heart Assist,Vascular Assist Device,Vascular Assist Devices,Ventricle Assist Device,Ventricle, Artificial,Ventricle, Artificial Heart,Ventricle-Assist Devices,Ventricles, Artificial,Ventricles, Artificial Heart,Ventricular Assist Devices
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
February 1998, The Annals of thoracic surgery,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
January 1999, Perfusion,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
April 1999, The Annals of thoracic surgery,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
October 1997, Journal of cardiothoracic and vascular anesthesia,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
December 2002, Journal of cardiothoracic and vascular anesthesia,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
September 1997, Perfusion,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
November 2014, Artificial organs,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
September 2015, Lancet (London, England),
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
December 2006, Perfusion,
F Mlejnsky, and A A Klein, and J Lindner, and P Maruna, and J Kvasnicka, and T Kvasnicka, and T Zima, and O Pecha, and M Lips, and J Rulisek, and M Porizka, and P Kopecky, and J Kunstyr
January 1995, Heart and vessels,
Copied contents to your clipboard!